Advances on phytoestrogen intervening breast cancer
Zhao, L.-c.; Tang, L.-j.; Li, Q.-l.; Liu, J.-g.
Zhongguo Zhong Yao Za Zhi 31(12): 957-960
2006
ISSN/ISBN: 1001-5302 PMID: 17048636 Document Number: 599675
Phytoestrogen is the bioactive substance from plant, with structure is very simliar to that of estrogen. Phytoestrogen is mainly comprises of isoflavone, lignan and coumarin. Epidemiological restrarch shows that the increasing the uptake phytoestrogen of can reduce the morbidities of breast and other cancers. In this paper, the food source, characteristic and relevant researches both in vitro and in vivo were reviewed, and its mechanisms of intervening breast cancer were also discussed.
Document emailed within 1 workday
Related Documents
Rabinowitz, B. 2002: Understanding and intervening in breast cancer's emotional and sexual side effects Current Women's Health Reports 2(2): 140-147Pavesić, I. 1974: Short retrospection on the advances of x-ray diagnosis of the breast and importance of the x-ray apparatus with a molybdenum anode (senograph) in the early diagnosis of breast cancer Lijecnicki Vjesnik 96(9): 557-561
Smellie, W.J.; Sacks, N.P. 1994: Recent advances in the treatment of breast cancer Postgraduate Medical Journal 70(822): 243-246
2009: Breast cancer. Advances in diagnosis and treatment Mayo Clinic Health Letter Suppl: 1-8
Walker, B.K.; Subramanian, V.P. 1980: Recent advances in breast cancer management West Virginia Medical Journal 76(9): 236-241
Fedotcheva, T.A.; Shirokih, K.E.; Matyushin, A.I.; Rzheznikov, V.M.; Kovtun, V.Y.; Shimanovskii, N.L. 2015: Cytoprotective Effects of Phytoestrogen Genistein against Cancer Cells Biofizika 60(6): 1151-1156
Chagpar, A.B. 2004: Advances in the management of localized breast cancer: an overview Journal of the Kentucky Medical Association 102(5): 202-208
Ma, C.-D.; Shen, K.-W.; Shen, Z.-Z. 2008: Advances in research on treatment of breast cancer with lapatinib Zhonghua Zhong Liu Za Zhi 30(5): 321-324
Pierga, J.-Y. 2013: Breast cancer: major therapeutic advances but mortality remains high La Revue du Praticien 63(10): 1359-1361
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82